160 related articles for article (PubMed ID: 12400712)
1. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis.
Hanft JR; Surprenant MS
J Foot Ankle Surg; 2002; 41(5):291-9. PubMed ID: 12400712
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
Marston WA; Hanft J; Norwood P; Pollak R;
Diabetes Care; 2003 Jun; 26(6):1701-5. PubMed ID: 12766097
[TBL] [Abstract][Full Text] [Related]
3. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.
Gentzkow GD; Iwasaki SD; Hershon KS; Mengel M; Prendergast JJ; Ricotta JJ; Steed DP; Lipkin S
Diabetes Care; 1996 Apr; 19(4):350-4. PubMed ID: 8729158
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
Veves A; Sheehan P; Pham HT
Arch Surg; 2002 Jul; 137(7):822-7. PubMed ID: 12093340
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
8. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.
Veves A; Falanga V; Armstrong DG; Sabolinski ML;
Diabetes Care; 2001 Feb; 24(2):290-5. PubMed ID: 11213881
[TBL] [Abstract][Full Text] [Related]
9. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
10. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
Cazzell S
Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
[TBL] [Abstract][Full Text] [Related]
12. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
Snyder RJ; Shimozaki K; Tallis A; Kerzner M; Reyzelman A; Lintzeris D; Bell D; Rutan RL; Rosenblum B
Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
[TBL] [Abstract][Full Text] [Related]
13. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers.
Ananian CE; Dhillon YS; Van Gils CC; Lindsey DC; Otto RJ; Dove CR; Pierce JT; Saunders MC
Wound Repair Regen; 2018 May; 26(3):274-283. PubMed ID: 30098272
[TBL] [Abstract][Full Text] [Related]
15. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study.
You HJ; Han SK; Lee JW; Chang H
Wound Repair Regen; 2012; 20(4):491-9. PubMed ID: 22672334
[TBL] [Abstract][Full Text] [Related]
16. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
18. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.
Caravaggi C; De Giglio R; Pritelli C; Sommaria M; Dalla Noce S; Faglia E; Mantero M; Clerici G; Fratino P; Dalla Paola L; Mariani G; Mingardi R; Morabito A
Diabetes Care; 2003 Oct; 26(10):2853-9. PubMed ID: 14514591
[TBL] [Abstract][Full Text] [Related]
19. Treatment of postoperative lower extremity wounds using human fibroblast-derived dermis: a retrospective analysis.
Carlson RM; Smith NC; Dux K; Stuck RM
Foot Ankle Spec; 2014 Apr; 7(2):102-7. PubMed ID: 24521756
[TBL] [Abstract][Full Text] [Related]
20. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
